A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Results
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

The present protocol describes a step-by-step, reproducible model of unilateral ureteral obstruction.

Abstract

Unilateral ureteral obstruction (UUO) is a common cause of chronic kidney disease (CKD), leading to the progression of renal interstitial fibrosis and ultimately resulting in irreversible kidney damage. The alleviation of UUO is crucial. Several animal models of reversible unilateral ureteral obstruction (RUUO) have been established in the literature, enabling the observation of structural changes and functional damage while also simulating physiological and pathophysiological changes following the relief of ureteral obstruction. In this study, a reversible obstruction model was established in the unilateral murine ureter using a silicone tube. Significant renal damage was observed prior to obstruction relief, with partial recovery noted afterward. Unlike UUO, this model prevents progressive hydronephrosis, leading to distinct pathological outcomes. This simple surgical procedure demonstrates a high success rate and holds promise as a classical model for investigating reversible obstructive nephropathy and potential treatments for renal interstitial fibrosis. Furthermore, it provides a practical platform for studying the mechanisms of recovery from obstructive nephropathy, renal cell regeneration, and tissue remodeling.

Introduction

Urethral obstruction significantly contributes to renal interstitial fibrosis and chronic kidney disease (CKD), potentially leading to irreversible structural damage and functional impairments in the kidney1. While unilateral ureteral obstruction (UUO) is widely used to study kidney injury and CKD, it does not accurately replicate the spontaneous recovery mechanisms that occur after the removal of an obstruction. The UUO model involves ligating the left ureter with sutures, resulting in permanent obstruction, ureteral dilation, hydronephrosis, compression of the renal parenchyma, and cortical thinning. Histological examination typically reveals

Protocol

This animal study adhered to the guidelines of the Declaration of Helsinki and was approved by the Research Ethics Committee of the Children's Hospital of Chongqing Medical University. A total of 27 male Sprague Dawley (SD) rats were commercially obtained and housed in the Laboratory Animal Center of the Children's Hospital of Chongqing Medical University (SPF, license number: SYXK (Chongqing) 2007-0016). The rats were maintained under controlled temperature conditions with a 12-h light/dark cycle and had ad libitum access to food and water.

The protocol was conducted on male SD rats aged 6-8 weeks and is applicable to rats

Results

The effects of UUO and its subsequent release (RUUO) on body weight, kidney weight, kidney volume, and serum creatinine (Scr) levels were evaluated, as summarized in Table 1. Data are presented as mean ± standard deviation (SD), with n = 5 per group.

At 6 weeks, the native group exhibited a mean body weight of 234 g ± 16 g, kidney weight of 0.9107 g ± 0.0475 g, and kidney volume of 0.8962 cm³ ± 0.0502 cm³. By 8 weeks, the control group showed sign...

Discussion

This model employs a silicone tube to encircle the ureter, providing structural support, followed by ligation with a silk thread to induce complete ureteral obstruction through compression. After seven days, the ligation and silicone tube are removed to facilitate kidney decompression and the restoration of urinary tract integrity and functionality.

Silicone tubing, manufactured from silicone elastomers, offers excellent flexibility, biocompatibility, chemical resistance, and thermal stability...

Disclosures

None.

Acknowledgements

This work was supported by the Program for Youth Innovation in Future Medicine, Chongqing Medical University (W0056), Chongqing Science and Health Joint TCM Technology Innovation and Application Development Project (2020ZY023877).

Materials

NameCompanyCatalog NumberComments
ForcepsShanghai Medical Devices Co.,Ltd20220032
GauzeSichuan Kelun Co., Ltd20172140152
Hematoxylin and Eosin Stain KitSolarbioG1120
Insulin needlesKDL Medical Devices20193140938
Masson’s Trichrome Stain KitSolarbioG1340
Medical Cotton ballsSichuan Kelun Co., Ltd20170037
Medical Cotton sticksSichuan Kelun Co., Ltd20172140026
Methylene blueTianjin Dengfeng Chemical Reagent Factory14038-43-8
Microscopic forcepsSuqian Shifeng Medical Devices Co., LtdS50985
Needle holdersSuqian Shifeng Medical Devices Co., LtdS7005
Povidone-iodine SolutionSichuan Kelun Co., Ltd514001
SalineSichuan Kelun Co., Ltd20220004
SD RatsSPF(Beijing)Biotechnology Co.,LtdD025
Silicone tubingTaizhou Chunshi New Materials Co., LtdCS356
Silk suture Qiangsheng Medical Devices Co.,LtdSA84G
Surgical bladeHuanan Yunyue Medical Devices Co.,LtdCE0434
Surgical scissorsShanghai Medical Devices Co.,LtdJ21130
SyringeTongmai medical devices20183140304
Tissue ForcepsJiangxi Yuyuan Medical Equipment Co., LtdJ36030

References

  1. Chaves, L. D. et al. Contrasting effects of systemic monocyte/macrophage and CD4+ t cell depletion in a reversible ureteral obstruction mouse model of chronic kidney disease. Clin Dev Immunol. 2013, 836989 (2013).
  2. Chevalier, R. L., Forbes, M. S., Thornhill, B. A. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int. 75 (11), 1145-1152 (2009).
  3. Aranda-Rivera, A. K. et al. Sulforaphane protects from kidney damage during the release of unilateral ureteral obstruction (RUUO) by activating nuclear factor erythroid 2-related factor 2 (nrf2): Role of antioxidant, anti-i

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Explore More Articles

Obstructive nephropathyrenal fibrosisRUUOrenal regeneration

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved